-
1
Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET
Published 2014-08-01Subjects: “…lenalidomide…”
Get full text
Article -
2
Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET
Published 2012-01-01Subjects: “…myeloma, CT/PET,lenalidomide…”
Get full text
Article -
3
Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET
Published 2012-06-01Subjects: “…myeloma, CT/PET,lenalidomide…”
Get full text
Article -
4
-
5
Bioequivalence study between two formulations of 10mg lenalidomide capsules in healthy male subjects under fasting conditions
Published 2023-12-01Subjects: “…lenalidomide…”
Get full text
Article -
6
Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
Published 2018-06-01Subjects: Get full text
Article -
7
Therapeutic Benefits of Lenalidomide in Hematological Malignancies
Published 2019-04-01Subjects: “…lenalidomide…”
Get full text
Article -
8
Modern approaches to the treatment of relapsed follicular lymphoma
Published 2022-07-01Subjects: Get full text
Article -
9
Myelodysplastic syndromes: therapeutic problems and decisions (review)
Published 2014-07-01Subjects: Get full text
Article -
10
Magnetic and pH-Sensitive dual actuation of biohybrid microswimmer of targeted drug release suitable for cancer cell microenvironment
Published 2025-06-01Subjects: Get full text
Article -
11
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
Published 2014-12-01Subjects: “…Nocardia paucivorans, Brain Abscess, Multiple Myeloma, Lenalidomide…”
Get full text
Article -
12
Three-year progression-free survival of a patient with concomitant mucinous adenocarcinoma of the colon with peritoneal dissemination and multiple myeloma who received lenalidomide...
Published 2024-02-01Subjects: “…Lenalidomide…”
Get full text
Article -
13
Biological basis of immunomodulatory preparations using in treatment of multiple myeloma
Published 2022-11-01Subjects: Get full text
Article -
14
-
15
Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group
Published 2025-04-01Subjects: Get full text
Article -
16
Reposition of lenalidomide as a radiation protector based on LINCS gene expression signatures and its preclinical validation
Published 2025-04-01Subjects: “…Lenalidomide…”
Get full text
Article -
17
Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
Published 2015-12-01Subjects: Get full text
Article -
18
PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
Published 2017-08-01Subjects: Get full text
Article -
19
Lenalidomide and its impact on exanthematous reactions: a case report
Published 2025-04-01Subjects: “…Hypersensitivity. Late onset. Lenalidomide.…”
Get full text
Article -
20
Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
Published 2019-04-01Subjects: Get full text
Article